Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Naeije (Brussels, Belgium). Clinical trials in PAH: what do they tell us. School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease

Member's Comments

No comment yet.

Related content which might interest you: Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Clinical trials in pulmonary arterial hypertension: what they tell us Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 How do we know what works? Clinical trial end-points and quality of life assessment Source: Eur Respir Monogr 2018; 81: 99-132 Year: 2018 Clinical cases that I do not forget Source: Annual Congress 2012 - PG19 Imaging in the intensive care unit Year: 2012 Clinical trials are important for CAP and other LRTI syndromes: but how to understand and interpret? Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice Year: 2010 Diagnostic tests: what are the questions and what do we know so far? Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies Year: 2020 Ask the Expert: Clinical dilemmas in asthma Source: Breathe 2009; 5: 346-351 Year: 2009 Clinical trials: registration and transparency Source: Eur Respir J 2016; 47:1342-1344 Year: 2016 What could we learn from ongoing therapeutic trials? Source: ERS Research Seminar Year: 2015 Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Source: Eur Respir J 2014; 44: 1123-1126 Year: 2014 Pathology: what do we actually want to know? Source: Annual Congress 2008 - Multidisciplinary approach in interstitial lung disease Year: 2008 Randomised controlled trials in cystic fibrosis: what, when and how? Source: Eur Respir J 2011; 37: 991-993 Year: 2011 Randomised controlled trials and real-life studies: two answers for one question Source: Eur Respir Rev, 27 (149) 180080; 10.1183/16000617.0080-2018 Year: 2018 Microbiological diagnosis and clinical outcome: where are we? Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful? Year: 2008 Clinical case discussion: How clinical trials inform antibiotic stewardship Source: ERS webinar 2022: Clinical case discussion: How clinical trials inform antibiotic stewardship Year: 2022 Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015 Chest drainage in clinical practice - how much do we think we know? Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019